about
Towards a systems approach for chronic diseases, based on health state modeling.Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathwayNon-alcoholic fatty liver disease: An expanded reviewNAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis.Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients.Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients.Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).Metabolomic Fingerprinting in the Comprehensive Study of Liver Changes Associated with Onion Supplementation in Hypercholesterolemic Wistar RatsTherapeutic application of GPR119 ligands in metabolic disorders.Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.Peretinoin as an adjuvant therapy for hepatocellular carcinoma.Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.Is That Possible to Stop or Cease the NASH to Turn into HCC?The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.Effects of telmisartan on improving leptin resistance and inhibiting hepatic fibrosis in rats with non-alcoholic fatty liver disease.NAFLD: Is There Anything New under the Sun?Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.Nonalcoholic fatty liver disease: Evolving paradigms.Non-alcoholic Fatty Liver Disease: A Clinical Update.Updates on Dietary Models of Non-Alcoholic Fatty Liver Disease: Current Studies and Insights.Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling.Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression.IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.Hypothermic Machine Preservation of the Liver: State of the Art.Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis.Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease.Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions.Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012.Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study.Roles of p53 in extrinsic factor-induced liver carcinogenesisTranscriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular CarcinomaThe Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition
P2860
Q30491730-2DE2EC6C-EE90-4EEE-AF75-64EE75166ACDQ33612522-66AF5891-4E79-4093-A6C4-BE69908CEBF3Q33789868-5215FEFE-36EB-4F49-AE77-A959D4A92262Q33844463-5CD0458E-9E85-4A59-B9E6-6035A833D2A7Q33877578-E2620537-AB29-44DE-ACC2-F701403AFDBCQ37612864-F8D3FA9B-D618-4591-8690-908C4F439181Q37669343-BB5D0533-2A4D-4654-A0DC-BBFE30F34DC2Q37673110-41D63E39-AC7B-48BF-8C3E-66483C592967Q37690687-A91E33DA-3ACB-4287-80DA-EACDD81F3A4FQ38655382-0B4E5772-4E4C-43A6-973C-24FAD862CFD3Q38681686-F4BBFB87-AFC7-469D-BC15-F295644EF7BDQ38959682-24D087BC-CA65-4B5C-95B3-7BCC1EF1772FQ39280379-31F2DF60-8338-4CC6-8725-0BDBC2E20B48Q39451496-44D34A58-02A5-49B9-ACD4-51735EF53942Q39471203-53132163-BB60-467A-86A5-6A6379FE1827Q41050215-F7D90D56-1348-423A-964F-EEBFB36B1D7CQ41195503-82B77B04-5081-47EE-AE20-E99A70894C44Q41672157-4EDF203A-0255-4E0A-8F56-E13DFEF2E96FQ42365749-A12839AF-5A99-401C-B1A5-35C315435C16Q42367659-4035FCC0-96D1-41AD-931C-2E4A7FA29C67Q42695154-6C99CEE9-E2E0-4FD5-AEF8-4427ECB98CB0Q47100244-1C320620-0A87-4E00-9683-E244EF5A085FQ47721272-E2AD8363-7E62-4D48-BD6A-847039C69DF3Q48171878-DBC85389-CC94-4593-9286-EB8B179DA0ABQ49387786-0124EE52-E030-4ECC-830A-DB913850D84DQ50077361-6528BDAD-1C4B-4DC7-A1A6-3231D382EAA7Q50147806-222F38D5-DE34-4FB6-8E94-A4DF6A8EA1D9Q50455460-3A87A722-B140-4D11-BF55-B21B0476AB10Q52582325-6A92D5BB-ACC2-4BE8-891E-749020367968Q52643514-9D373CA0-98C1-41F8-91E5-5D1415D01D01Q52668406-BA1355E1-0CB5-442B-905C-DBA19FD7C4B9Q52699058-BE5114D2-C8C8-44B9-829D-9E6602646DBAQ55251257-D5FD0585-D7F5-43D3-A4B2-709E9B936B48Q55266683-A0C9B49C-24D5-4AFD-9DBC-5262E072C647Q55315481-7861CFAD-ED94-4934-800C-8B03705F3A0BQ55360775-EA12A26B-4602-4C47-87FD-556AF6F4CE9AQ55402006-CA014C57-02F1-4640-A94F-3D7D4B1AE838Q56972496-0B653D5C-DF4B-47D4-AB23-E4D4A698D04FQ57152054-76F79174-76A6-4889-BDF2-56431D61BC67Q57300008-C7FCFF44-EBDC-4A6B-8454-DB6ACFFA77FE
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Natural Course of Non-Alcoholic Fatty Liver Disease
@ast
The Natural Course of Non-Alcoholic Fatty Liver Disease
@en
The Natural Course of Non-Alcoholic Fatty Liver Disease
@nl
type
label
The Natural Course of Non-Alcoholic Fatty Liver Disease
@ast
The Natural Course of Non-Alcoholic Fatty Liver Disease
@en
The Natural Course of Non-Alcoholic Fatty Liver Disease
@nl
prefLabel
The Natural Course of Non-Alcoholic Fatty Liver Disease
@ast
The Natural Course of Non-Alcoholic Fatty Liver Disease
@en
The Natural Course of Non-Alcoholic Fatty Liver Disease
@nl
P2860
P921
P3181
P356
P1476
The Natural Course of Non-Alcoholic Fatty Liver Disease
@en
P2093
Leon Anton Adams
Luis Calzadilla Bertot
P2860
P3181
P356
10.3390/IJMS17050774
P407
P5008
P577
2016-05-20T00:00:00Z